Dear Mr R. Tuber,
First of all we will thank you for your article dated spring 2004 (pages 29-31) of body of science magazine.
Norma’s policy is to develop, produce and sale pharmaceutical products for the Greek market mainly. Few exportations we do well in Central America.
Our target is to protect the public health world wide.
The advertising of the pharmaceutical products it is not permitted by law. For this reason we had not try to give you an answer regarding your excellent article.
We are in note for the counterfeit products and we started taking several legal measures against bootleg. We informed the Greek and European authorities for the illegal market and we wait there responses.
In order to continue to protect the patients, we changed the labelling with a new photochromic (patented) label.
Please inform us for your address in order to send you the new packaging materials if needed.
Important: additionally, please inform your readers that Nandrolone Decanoate / Norma is a product witch should be administered only by medical prescription.
More information of our company is available on our web site (www.normahellas.gr ).
Thanks in advance for your kind collaboration and we remain in your disposal for any additional info.
Best regards,
Savvas Kyritsis
General Manager